Press Resease

Ablation Technology Market by Product Type (Hydrothermal, Microwave, Cryotherapy, Electrical, Laser, Ultrasound, and Radiofrequency), by Application (Cancer, Cardiovascular, Orthopedics, Pain Management, Urology, Gynecology, and Others), and by End Use (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Published Date: 16-Jul-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-544 Status : Published

Global ablation technology market expected to generate revenue of around USD 6.7 billion by end of 2024, growing at a CAGR of around 10.8% between 2018 and 2024. The global ablation technology market is primarily driven by growing prevalence of life-threatening diseases such as cancer and cardiovascular disorders across the globe.

Description

The report covers forecast and analysis for the ablation technology market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the ablation technology market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the ablation technology market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the ablation technology market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type, application, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Ablation Technology Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view on the ablation technology market by segmenting the market based on product type, application, end use, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

The ablation technology market is segmented on the basis of product type as hydrothermal, microwave, cryotherapy, electrical, laser, ultrasound, and radiofrequency. By product, the radiofrequency segment is estimated cover maximum market value share due to its comparatively lower price as compared to the other technologies which make it more preferable among the patients.

Based on application, ablation technology is segmented as cancer, cardiovascular, orthopedics, pain management, urology, gynecology, and others. By application, cancer is expected to occupy the largest market value share due to the increasing cases of cancer which has created the upsurge need for the prominent advanced technology for its treatment. 

Based on end use, ablation technology is segmented as hospitals, clinics, and others. By end user, the hospital segment is estimated to be the prominent segment and will show significant CAGR growth over estimated time.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further classification into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for ablation technology based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Johnson & Johnson, Boston Scientific Corporation, Medtronic plc, Medical, Inc., Olympus Corporation, Conmed Corporation, AtriCure, Inc., AngioDynamics, Inc., BTG plc, Stryker Corporation, Hologic, Inc., Misonix, Inc., Elekta AB., EDAP TMS S.A., Terumo Corporation, Abbott Laboratories, Integra Life Sciences Holdings Corporation, Merit Medical Systems, Halyard Health, Inc. and Japan Lifeline Co., Ltd., among others.

This report segments the global ablation technology market as follows:
 
Global Ablation Technology Market: By Product Type

  • Hydrothermal
  • Microwave
  • Cryotherapy 
  • Electrical
  • Laser
  • Ultrasound
  • Radiofrequency

Global Ablation Technology Market: By Application

  • Cancer
  • Cardiovascular
  • Orthopedics
  • Pain Management
  • Urology 
  • Gynecology
  • Others

Global Ablation Technology Market: By End-Use

  • Hospitals
  • Clinics
  • Others

Global Ablation Technology Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global ablation technology market, 2015 - 2024 (USD Billion)
    • 2.2. Global ablation technology market : Snapshot
  •  
  • Chapter 3. Global Ablation Technology- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global ablation technology market drivers: Impact analysis
      • 3.2.2. Increasing prevalence of Cancer
      • 3.2.3. Technological Advancement
    • 3.3. Market Restraints
      • 3.3.1. Global ablation technology market restraints: Impact analysis
      • 3.3.2. Technology can't be used for the treatment of large tumors
    • 3.4. Opportunities
      • 3.4.1. Increasing health awareness
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product Type
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by end Use
  •  
  • Chapter 4. Global Ablation Technology Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global ablation technology market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Ablation Technology Market - Product Type Segment Analysis
    • 5.1. Global ablation technology market: product type overview
      • 5.1.1. Global ablation technology market revenue share, by product type, 2018 and 2024
    • 5.2. Hydrothermal
      • 5.2.1. Global ablation technology market for hydrothermal, 2015 - 2024 (USD Billion)
    • 5.3. Microwave
      • 5.3.1. Global ablation technology market for microwave, 2015 - 2024 (USD Billion)
    • 5.4. Cryotherapy
      • 5.4.1. Global ablation technology market for cryotherapy , 2015 - 2024 (USD Billion)
    • 5.5. Electrical
      • 5.5.1. Global ablation technology market for electrical, 2015 - 2024 (USD Billion)
    • 5.6. Laser
      • 5.6.1. Global ablation technology market for laser, 2015 - 2024 (USD Billion)
    • 5.7. Ultrasound
      • 5.7.1. Global ablation technology market for ultrasound, 2015 - 2024 (USD Billion)
    • 5.8. Radiofrequency
      • 5.8.1. Global ablation technology market for radiofrequency, 2015 - 2024
  •  
  • Chapter 6. Global Ablation Technology Market - By Application Segment Analysis
    • 6.1. Global ablation technology market: application overview
      • 6.1.1. Global ablation technology market revenue share, by application, 2018 and 2024
    • 6.2. Cancer
      • 6.2.1. Global ablation technology market for cancer, 2015 - 2024 (USD Billion)
    • 6.3. Cardiovascular
      • 6.3.1. Global ablation technology market for cardiovascular, 2015 - 2024 (USD Billion)
    • 6.4. Orthopedics
      • 6.4.1. Global ablation technology market for wearable0020sensor, 2015 - 2024 (USD Billion)
    • 6.5. Pain management
      • 6.5.1. Global ablation technology market for pain management, 2015 - 2024 (USD Billion)
    • 6.6. Urology
      • 6.6.1. Global ablation technology market for urology, 2015 - 2024 (USD Billion)
    • 6.7. Gynecology
      • 6.7.1. Global ablation technology market for gynecology, 2015 - 2024 (USD Billion)
    • 6.8. Others
      • 6.8.1. Global ablation technology market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Ablation Technology Market - End Use Segment Analysis
    • 7.1. Global ablation technology market: end use overview
      • 7.1.1. Global ablation technology market revenue share, by end user, 2018 and 2024
    • 7.2. Hospitals
      • 7.2.1. Global ablation technology market for others, 2015 - 2024 (USD Billion)
    • 7.3. Clinics
      • 7.3.1. Global ablation technology market for clinics, 2015 - 2024 (USD Billion)
    • 7.4. Others
      • 7.4.1. Global ablation technology market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Ablation Technology Market - Regional Segment Analysis
    • 8.1. Global ablation technology market: regional overview
      • 8.1.1. Global ablation technology market revenue share, by region, 2018 and 2024
      • 8.1.2. North America
        • 8.1.2.1. North America ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.1.2.2. North America ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.1.2.3. North America ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.1.3. U.S.
        • 8.1.3.1. U.S. Ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.1.3.2. U.S. Ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.1.3.3. U.S. Ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.1.4. Canada
        • 8.1.4.1. Canada ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.1.4.2. Canada ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.1.4.3. Canada ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
    • 8.2. Europe
      • 8.2.1. Europe ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.2.2. Europe ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.2.3. Europe ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.2.4. U.K.
        • 8.2.4.1. U.K. Ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.2.4.2. U.K. Ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.2.4.3. U.K. Ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.2.5. Germany
        • 8.2.5.1. Germany ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.2.5.2. Germany ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.2.5.3. Germany ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.2.6. France
        • 8.2.6.1. France ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.2.6.2. France ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.2.6.3. France ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.2.7. Rest of Europe
        • 8.2.7.1. Rest of Europe ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.2.7.2. Rest of Europe ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.2.7.3. Rest of Europe ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
    • 8.3. Asia Pacific
      • 8.3.1. Asia Pacific ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.3.2. Asia Pacific ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.3.3. Asia Pacific ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.3.4. China
        • 8.3.4.1. China ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.4.2. China ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.4.3. China ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.3.5. Japan
        • 8.3.5.1. Japan ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.5.2. Japan ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.5.3. Japan ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.3.6. India
        • 8.3.6.1. India ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.6.2. India ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.6.3. India ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.3.7. Rest of Asia Pacific
        • 8.3.7.1. Rest of Asia Pacific ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.3.7.2. Rest of Asia Pacific ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.3.7.3. Rest of Asia Pacific ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
    • 8.4. Latin America
      • 8.4.1. Latin America ablation technology market revenue, by product type, 2015 - 2024(USD Billion)
      • 8.4.2. Latin America ablation technology market revenue, by application, 2015 - 2024(USD Billion)
      • 8.4.3. Latin America ablation technology market revenue, by end use, 2015 - 2024(USD Billion)
      • 8.4.4. Brazil
        • 8.4.4.1. Brazil ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.4.4.2. Brazil ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.4.4.3. Brazil ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
      • 8.4.5. Rest of Latin America
        • 8.4.5.1. Rest of Latin America ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
        • 8.4.5.2. Rest of Latin America ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
        • 8.4.5.3. Rest of Latin America ablation technology market revenue, by end use, 2015 - 2024 (USD Billion)
    • 8.5. Middle East and Africa
      • 8.5.1. Middle East and Africa ablation technology market revenue, by product type, 2015 - 2024 (USD Billion)
      • 8.5.2. Middle East and Africa ablation technology market revenue, by application, 2015 - 2024 (USD Billion)
      • 8.5.3. Middle East and Africa ablation technology market revenue, by end user, 2015 - 2024 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Johnson & Johnson
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Boston Scientific Corporation
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Medtronic plc
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Medical, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Olympus Corporation
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Conmed Corporation
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. AtriCure, Inc.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. AngioDynamics, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. BTG plc
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Stryker Corporation
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Hologic, Inc.
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Misonix, Inc.
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments
    • 9.13. Elekta AB.
      • 9.13.1. Overview
      • 9.13.2. Financials
      • 9.13.3. Product portfolio
      • 9.13.4. Business strategy
      • 9.13.5. Recent developments
    • 9.14. EDAP TMS S.A
      • 9.14.1. Overview
      • 9.14.2. Financials
      • 9.14.3. Product portfolio
      • 9.14.4. Business strategy
      • 9.14.5. Recent developments
    • 9.15. Terumo Corporation
      • 9.15.1. Overview
      • 9.15.2. Financials
      • 9.15.3. Product portfolio
      • 9.15.4. Business strategy
      • 9.15.5. Recent developments
    • 9.16. Abbott Laboratories
      • 9.16.1. Overview
      • 9.16.2. Financials
      • 9.16.3. Product portfolio
      • 9.16.4. Business strategy
      • 9.16.5. Recent developments
    • 9.17. Integra Life Sciences Holdings Corporation
      • 9.17.1. Overview
      • 9.17.2. Financials
      • 9.17.3. Product portfolio
      • 9.17.4. Business strategy
      • 9.17.5. Recent developments
    • 9.18. Merit Medical Systems
      • 9.18.1. Overview
      • 9.18.2. Financials
      • 9.18.3. Product portfolio
      • 9.18.4. Business strategy
      • 9.18.5. Recent developments
    • 9.19. Halyard Health, Inc.
      • 9.19.1. Overview
      • 9.19.2. Financials
      • 9.19.3. Product portfolio
      • 9.19.4. Business strategy
      • 9.19.5. Recent developments
    • 9.20. Japan Lifeline Co., Ltd
      • 9.20.1. Overview
      • 9.20.2. Financials
      • 9.20.3. Product portfolio
      • 9.20.4. Business strategy
      • 9.20.5. Recent developments

Methodology

Free Analysis

The ablation technology is used for the treatment of several healthcare problems which include cancer, cardiovascular problems, orthopedics, pain management, urology, gynecology, and many others. The treatment based on the ablation technology involves negligible invasion along with the minimum damage to the tissues and organs surrounding the infected organ. The inclination of the patients towards the advanced technology based treatment which gives instant results with minimum side effects are projected to drive the ablation technology market over the forecast period. 

As per the World Health Organization, cardiovascular diseases are one of the main causes of death worldwide. About 17.5 million people died due to cardiovascular disease in 2015 representing 31% of all global deaths. Additionally, as per the World Health Organization estimates, 8.8 million deaths resulted due to cancer in 2015. Globally, approximately 1 in 6 deaths is because of cancer. Also, the global burden of these disorders is increasing further owing to the increasing geriatric population base across the world. According to the World Health Organization, the number of people who aged 60 or above is expected to be doubled by 2050 growing from 962 million globally in 2017 to 2.1 billion in 2050. Thus, ablation technology market has vast potential in terms of large patient pool and upsurge need for significant treatment.

Global Ablation Technology Market

The ablation technology market is segmented on the basis of product type as hydrothermal, microwave, cryotherapy, electrical, laser, ultrasound and the radiofrequency. By product, the radiofrequency segment is estimated to cover the maximum market value share due to its comparatively lower price as compared to the other technologies which make it more preferable for the patients.

Based on application, ablation technology is segmented as cancer, cardiovascular, orthopedics, pain management, urology, gynecology, and others. By application, cancer is expected to occupy the largest market value share due to the increasing cases of cancer which has created the upsurge need for the treatment.
 
Based on end-use, ablation technology is segmented as hospitals, clinics, and others. By end user, the hospital segment is estimated to be the prominent segment and will show significant CAGR growth over estimated time.

North America is anticipated to be the dominant region in the ablation technology market over the forecast period. Favorable government policies supporting the invasion of new and advanced procedures for the treatment, development in the healthcare infrastructure, and research granted by the government and ruling authorities are expected to propel the growth of the ablation technology market in this region. Europe is the second largest market followed by the Asia Pacific. Increasing geriatric population base in the Asia Pacific region, especially India, China, and Japan is the significant accelerating factor for the growth of the ablation technology market in this region. Asia Pacific is expected to show the fastest CAGR growth during the forecast period while Latin America market is projected to grow at a low to moderate rate during the forecast period. The Middle East and Africa are also expected to cover the prominent market value share in the ablation technology global market.

Some of the key players in ablation technology market include Johnson & Johnson, Boston Scientific Corporation, Medtronic plc, Medical, Inc., Olympus Corporation, Conmed Corporation, AtriCure, Inc., AngioDynamics, Inc., BTG plc, Stryker Corporation, Hologic, Inc., Misonix, Inc, Elekta AB., EDAP TMS S.A., Terumo Corporation, Abbott Laboratories, Integra Life Sciences Holdings Corporation, Merit Medical Systems, Halyard Health, Inc. and Japan Lifeline Co., Ltd., among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social